$312 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 9 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 22.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KRTX | Sell | KARUNA THERAPEUTICS INC | $109,254,000 | -0.7% | 908,708 | -16.1% | 35.05% | -3.4% |
BOLT | New | BOLT BIOTHERAPEUTICS INC | $62,248,000 | – | 1,891,467 | +100.0% | 19.97% | – |
INZY | INOZYME PHARMA INC | $31,505,000 | -4.1% | 1,591,154 | 0.0% | 10.11% | -6.6% | |
PCVX | Sell | VAXCYTE INC | $27,757,000 | -53.0% | 1,405,421 | -36.8% | 8.90% | -54.3% |
AKUS | AKOUOS INC | $24,884,000 | -30.1% | 1,794,088 | 0.0% | 7.98% | -31.9% | |
ALGS | ALIGOS THERAPEUTICS INC | $19,933,000 | -17.8% | 876,548 | 0.0% | 6.40% | -20.0% | |
FUSN | FUSION PHARMACEUTICALS INC | $17,135,000 | -8.8% | 1,598,379 | 0.0% | 5.50% | -11.2% | |
ARQT | Sell | ARCUTIS BIOTHERAPEUTICS INC | $16,462,000 | -12.9% | 569,041 | -15.3% | 5.28% | -15.2% |
ETTX | Sell | ENTASIS THERAPEUTICS HLDGS I | $2,517,000 | -13.7% | 1,176,378 | -0.3% | 0.81% | -15.9% |
ITRM | Exit | ITERUM THERAPEUTICS PLC | $0 | – | -945,085 | -100.0% | -0.31% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
VAXCYTE INC | 12 | Q3 2023 | 19.5% |
INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
AKOUOS INC | 8 | Q3 2022 | 11.7% |
EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.